TABLET FORMULATION FOR P38 INHIBITOR AND METHOD

A tablet formulation is provided which includes a medicament which is a pharmaceutically acceptable salt of a p38 inhibitor, such as the p38 HCl salt of the structure Formula (I) and which has good physical stability when stored at up to 25 C./60% RH in closed containers with desiccant. The tablet f...

Full description

Saved in:
Bibliographic Details
Main Authors DAHLHEIM CHARLES E, MCGEORGE GARY, NARINGREKAR VIJAY H, DALI MANISHA M
Format Patent
LanguageEnglish
Published 09.02.2012
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A tablet formulation is provided which includes a medicament which is a pharmaceutically acceptable salt of a p38 inhibitor, such as the p38 HCl salt of the structure Formula (I) and which has good physical stability when stored at up to 25 C./60% RH in closed containers with desiccant. The tablet formulation will contain crospovidone as a tablet disintegrant, which, unlike croscarmellose sodium, will not cause disproportionation of the HCl salt to the free base of P38 inhibitor and thus will have acceptable dissolution properties even after storage at room temperature.
Bibliography:Application Number: US201013263877